Defining high probability when making a diagnosis of asthma in primary care: mixed-methods consensus workshop.
asthma
primary care
qualitative research
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
20 04 2020
20 04 2020
Historique:
entrez:
23
4
2020
pubmed:
23
4
2020
medline:
20
4
2021
Statut:
epublish
Résumé
Making the diagnosis of asthma is challenging. Guidelines recommend that clinicians identify a group at 'high probability' of asthma. High probability, however, is not numerically defined giving rise to uncertainty. The aim of this work was to build consensus on what constitutes a high probability of asthma in primary care. High probability was defined as the probability threshold at which there is enough information to make a firm diagnosis of asthma, and a subsequent negative test would not alter that opinion (assumed to be a false negative). Mixed-methods study. A consensus workshop using modified nominal group technique was held during an international respiratory conference. International conference attendees eligible if they had knowledge/experience of working in primary care, respiratory medicine and spoke English. Participants took part in facilitated discussions and voted over three rounds on what constituted a high probability of asthma diagnosis. The workshop was audio-recorded, transcribed and qualitatively analysed. Based on final votes, the mean value for a high probability of asthma in primary care was 75% (SD 7.6), representing a perceived trade-off between limiting the number of false positives (more likely if a lower threshold was used) and pragmatism on the basis that first-line preventive therapies (ie, low-dose inhaled corticosteroids) are relatively low risk. The need to review response to treatment was strongly emphasised for detecting non-responders and reviewing the diagnosis. A consensus probability of 75% was the threshold at which the primary care participants in this workshop felt confident to establish the diagnosis of asthma, albeit with the caveat that a review of treatment response was essential. Contextual factors, including availability and timing of tests and the ease with which patients could be reviewed, influenced participants' decision making.
Identifiants
pubmed: 32317260
pii: bmjopen-2019-034559
doi: 10.1136/bmjopen-2019-034559
pmc: PMC7204930
doi:
Substances chimiques
Adrenal Cortex Hormones
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e034559Subventions
Organisme : Chief Scientist Office
ID : CAF/17/01
Pays : United Kingdom
Organisme : Chief Scientist Office [UK]
ID : CAF/17/01
Pays : International
Informations de copyright
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: LD and HP are on the British Thoracic Society (BTS)/Scottish Intercollegiate Guideline Network (SIGN) asthma guideline development committee. ASh has previously served on the BTS/SIGN Asthma Guideline Committee and currently serves on Global Initiative for Asthma’s Scientific Committee. ASc is a member of the Committee of the German National Asthma Guideline (Nationale VersorgungsLeitlinie Asthma (NVL) Asthma).
Références
Chest. 2002 Apr;121(4):1051-7
pubmed: 11948032
BMJ. 2018 Jan 9;360:k29
pubmed: 29317387
Eur Respir J. 2019 Jan 10;53(1):
pubmed: 30309972
Am J Respir Crit Care Med. 2000 Jan;161(1):309-29
pubmed: 10619836
Thorax. 2017 Feb;72(2):109-116
pubmed: 27388487
NPJ Prim Care Respir Med. 2019 May 9;29(1):19
pubmed: 31073125
Health Expect. 2016 Jun;19(3):602-16
pubmed: 25523361
J Clin Epidemiol. 2012 Aug;65(8):846-54
pubmed: 22640568
BMJ Glob Health. 2019 May 23;4(3):e001435
pubmed: 31263586
J Clin Epidemiol. 2002 Dec;55(12):1201-6
pubmed: 12547450
Lancet. 2018 Jan 27;391(10118):350-400
pubmed: 28911920
Prim Care Respir J. 2012 Mar;21(1):19-27
pubmed: 22273628
NPJ Prim Care Respir Med. 2019 Jul 17;29(1):27
pubmed: 31316068
BMJ. 2017 Nov 1;359:j4218
pubmed: 29092826
NPJ Prim Care Respir Med. 2015 Jan 08;25:14101
pubmed: 25569634
JAMA. 2013 Jun 12;309(22):2327-8
pubmed: 23757080
Health Technol Assess. 1998;2(3):i-iv, 1-88
pubmed: 9561895
Eur Respir J Suppl. 2003 Jan;39:16s-22s
pubmed: 12572697
Br J Gen Pract. 2016 Mar;66(644):e152-7
pubmed: 26917656
N Engl J Med. 1980 May 15;302(20):1109-17
pubmed: 7366635
Chest. 2007 Oct;132(4):1151-61
pubmed: 17573515
Eur Respir J. 2016 Feb;47(2):410-9
pubmed: 26828055
Dtsch Med Wochenschr. 2009 Oct;134(41):2053-8
pubmed: 19802765
JAMA. 2017 Jan 17;317(3):269-279
pubmed: 28114551
Br J Gen Pract. 1997 Aug;47(421):487-92
pubmed: 9302787
BMC Pulm Med. 2009 Jul 10;9:31
pubmed: 19591673